Filing Details

Accession Number:
0001104659-21-115916
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-15 16:03:13
Reporting Period:
2021-09-15
Accepted Time:
2021-09-15 16:03:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1644963 Avenue Therapeutics Inc. ATXI Pharmaceutical Preparations (2834) 474113275
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1715291 Walter Joseph Vazzano 1140 Avenue Of The Americas, Floor 9
New York NY 10036
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-09-15 7,160 $1.62 65,252 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. On September 15, 2021, a total of 7,160 shares were sold by the Company at a weighted average sales price of $1.62 in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies.